131 related articles for article (PubMed ID: 25340602)
1. Recurrent membranoproliferative glomerulonephritis type I after kidney transplantation: a 17-year single-center experience.
Green H; Rahamimov R; Rozen-Zvi B; Pertzov B; Tobar A; Lichtenberg S; Gafter U; Mor E
Transplantation; 2015 Jun; 99(6):1172-7. PubMed ID: 25340602
[TBL] [Abstract][Full Text] [Related]
2. Impact of recurrent glomerulonephritis on renal graft survival.
Toledo K; Pérez-Sáez MJ; Navarro MD; Ortega R; Redondo MD; Agüera ML; Rodríguez-Benot A; Aljama P
Transplant Proc; 2011; 43(6):2182-6. PubMed ID: 21839228
[TBL] [Abstract][Full Text] [Related]
3. Recurrent and de novo glomerulonephritis following renal transplantation: higher rates of rejection and lower graft survival.
Mirioglu S; Caliskan Y; Goksoy Y; Gulcicek S; Ozluk Y; Sarihan I; Seyahi N; Kilicaslan I; Turkmen A; Sever MS
Int Urol Nephrol; 2017 Dec; 49(12):2265-2272. PubMed ID: 29039058
[TBL] [Abstract][Full Text] [Related]
4. The effect of recurrent glomerulonephritis and acute rejection episodes in zero human leukocyte antigen-mismatched kidney transplantation.
Jeon HJ; Kim YS; Lee SM; Ahn C; Ha J; Kim SJ; Kim DK
Transplant Proc; 2012 Apr; 44(3):600-6. PubMed ID: 22483448
[TBL] [Abstract][Full Text] [Related]
5. Recurrence of type I membranoproliferative glomerulonephritis after renal transplantation: analysis of the incidence, risk factors, and impact on graft survival.
Andresdottir MB; Assmann KJ; Hoitsma AJ; Koene RA; Wetzels JF
Transplantation; 1997 Jun; 63(11):1628-33. PubMed ID: 9197358
[TBL] [Abstract][Full Text] [Related]
6. Recurrent glomerular diseases after renal transplantation.
Karakayali FY; Ozdemir H; Kivrakdal S; Colak T; Emiroğlu R; Haberal M
Transplant Proc; 2006 Mar; 38(2):470-2. PubMed ID: 16549150
[TBL] [Abstract][Full Text] [Related]
7. HLA-identical sibling renal transplantation--a 21-yr single-center experience.
de Mattos AM; Bennett WM; Barry JM; Norman DJ
Clin Transplant; 1999 Apr; 13(2):158-67. PubMed ID: 10202612
[TBL] [Abstract][Full Text] [Related]
8. What kind of changes occurred in clinical characteristics of deceased kidney donor recipients after national allocation system in Turkey? A single-center retrospective analysis.
Solak I; Sezer TO; Toz H; Tatar E; Sozbilen M; Firat O; Hoscoskun C
Transplant Proc; 2012; 44(6):1598-600. PubMed ID: 22841223
[TBL] [Abstract][Full Text] [Related]
9. Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients.
Al Meshari K; Pall A; Chaballout A; El Gamal H; Al Mana H; Humaidan H; Alzayer F; Al Talhi M
Transplant Proc; 2013 May; 45(4):1423-6. PubMed ID: 23726587
[TBL] [Abstract][Full Text] [Related]
10. Recurrence and graft loss after kidney transplantation for henoch-schonlein purpura nephritis: a multicenter analysis.
Kanaan N; Mourad G; Thervet E; Peeters P; Hourmant M; Vanrenterghem Y; De Meyer M; Mourad M; Maréchal C; Goffin E; Pirson Y
Clin J Am Soc Nephrol; 2011 Jul; 6(7):1768-72. PubMed ID: 21734091
[TBL] [Abstract][Full Text] [Related]
11. [Living-donor kidney transplantation in the cyclosporine era].
Campise M; Tarantino A; Berardinelli L; Finazzi S; Montagnino G; Rossini G; Scalamogna M; Cesana B; Ponticelli C
G Ital Nefrol; 2002; 19(1):49-54. PubMed ID: 12165946
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of pretransplantation microchimerism on rejection-free survival in HLA-haploidentical family donor renal transplantation.
Joo SY; Song EY; Shin Y; Ha J; Kim SJ; Park MH
Transplantation; 2013 Jun; 95(11):1375-82. PubMed ID: 23519024
[TBL] [Abstract][Full Text] [Related]
13. Membranoproliferative glomerulonephritis recurrence after kidney transplantation: using the new classification.
Alasfar S; Carter-Monroe N; Rosenberg AZ; Montgomery RA; Alachkar N
BMC Nephrol; 2016 Jan; 17():7. PubMed ID: 26754737
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of kidney transplantation across a positive complement-dependent cytotoxicity crossmatch.
Riella LV; Safa K; Yagan J; Lee B; Azzi J; Najafian N; Abdi R; Milford E; Mah H; Gabardi S; Malek S; Tullius SG; Magee C; Chandraker A
Transplantation; 2014 Jun; 97(12):1247-52. PubMed ID: 24854670
[TBL] [Abstract][Full Text] [Related]
15. The fate of renal transplants in patients with IgA nephropathy.
Frohnert PP; Donadio JV; Velosa JA; Holley KE; Sterioff S
Clin Transplant; 1997 Apr; 11(2):127-33. PubMed ID: 9113449
[TBL] [Abstract][Full Text] [Related]
16. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
17. Analysis of transplant outcomes after five or six human leukocyte antigen-mismatched living donor kidney transplantation.
Lee HS; Kim MS; Kim YS; Joo DJ; Ju MK; Kim SJ; Kim SI; Huh KH; Park K
Transplant Proc; 2012 Jan; 44(1):273-5. PubMed ID: 22310631
[TBL] [Abstract][Full Text] [Related]
18. Harmful effect of preformed anti-MICA antibodies on renal allograft evolution in early posttransplantation period.
Sánchez-Zapardiel E; Castro-Panete MJ; Castillo-Rama M; Morales P; Lora-Pablos D; Valero-Hervás D; Ruiz-García R; Apaza J; Talayero P; Andrés A; Morales JM; Paz-Artal E
Transplantation; 2013 Jul; 96(1):70-8. PubMed ID: 23624543
[TBL] [Abstract][Full Text] [Related]
19. Pretransplant immunologic risk assessment of kidney transplant recipients with donor-specific anti-human leukocyte antigen antibodies.
Marfo K; Ajaimy M; Colovai A; Kayler L; Greenstein S; Lubetzky M; Gupta A; Kamal L; de Boccardo G; Masiakos P; Kinkhabwala M; Akalin E
Transplantation; 2014 Nov; 98(10):1082-8. PubMed ID: 24873780
[TBL] [Abstract][Full Text] [Related]
20. [Results of kidney transplantation at the Institute of Urology and Nephrology of the Serbian Clinical Center in Belgrade].
Lezanić V; Djukanović Lj; Marinković J; Blagojević-Lazić R; Radivojević D; Simić-Ogrizović S; Milutinović D; Borić Z; Djokić M; Krasojević-Kostić I; Marković V; Petrović M; Dujić A; Hadzi-Djokić J
Srp Arh Celok Lek; 2000; 128(5-6):149-56. PubMed ID: 11089414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]